Suchergebnisse - "antibodies"

PubPharm (8.502)

61

New European approval : Polatuzumab vedotin associated to rituximab, cyclophosphamide, doxorubicin and prednisone in previously untreated Diffuse Large B-Cell Lymphoma

enthalten in: Bulletin du cancer | 2022

von Turot, M. | Aspas Requena, G.

62

Nephropathy associated with monoclonal immunoglobulins : From clonal expansion B to renal toxicity of pathological immunoglobulins

enthalten in: Nephrologie & therapeutique | 2022

von Gueye, S. | Gauthier, M. | Benyahia, R. | +8

63

New European approval : Relatlimab/nivolumab in first -line treatment of advanced metastatic melanoma with less than 1% tumor expression of PD-L1

enthalten in: Bulletin du cancer | 2022

von Boileau, M. | Boussemart, L.

64

enthalten in: Revue medicale suisse | 2022

von Ammann, S.

65

Design of bimodular fusion proteins for redirecting a preexisting Epstein-Barr virus antibody response towards defined target cells

enthalten in: Medecine sciences : M/S | 2022

von Chêne, A. | Teillaud, J. | Viatte, L. | +1

66

Drug approval : Mosunetuzumab - third-line therapy in follicular lymphoma

enthalten in: Bulletin du cancer | 2022

von Gondran, C. | Ysebaert, L.

67

Biomarkers and functional tests in immediate hypersensitivity to SARS-CoV-2 mRNA vaccines

enthalten in: Revue francaise d'allergologie (2009) | 2022

von Nicaise-Roland, P. | Mehlal, S. | Bouz, C. | +1

68

Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors

enthalten in: Annales pharmaceutiques francaises | 2022

von Nasr Allah, M. | Pieragostini, R. | Oka, G. | +3

69

Interest of daratumumab in refractory AL amyloidosis in a 96-year-old patient

enthalten in: La Revue de medecine interne | 2022

von Vial, G. | Lafargue, A. | Mercié, P. | +2

70

Leber hereditary optic neuropathy : differential diagnosis

enthalten in: Journal francais d'ophtalmologie | 2022

von Orssaud, C.